Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Capital Expenditures (2022 - 2025)

Core Laboratories (CLB) has 4 years of Capital Expenditures data on record, last reported at $2.0 million in Q3 2025.

  • For Q3 2025, Capital Expenditures fell 72.48% year-over-year to $2.0 million; the TTM value through Sep 2025 reached $12.6 million, up 615.68%, while the annual FY2024 figure was $13.0 million, 1252.86% up from the prior year.
  • Capital Expenditures reached $2.0 million in Q3 2025 per CLB's latest filing, down from $3.5 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $7.3 million in Q3 2024 and bottomed at -$7.0 million in Q4 2022.
  • Average Capital Expenditures over 4 years is $1.5 million, with a median of $2.2 million recorded in 2023.
  • Peak YoY movement for Capital Expenditures: tumbled 92.74% in 2024, then soared 2098.73% in 2025.
  • A 4-year view of Capital Expenditures shows it stood at -$7.0 million in 2022, then increased by 2.24% to -$6.9 million in 2023, then surged by 163.68% to $4.4 million in 2024, then crashed by 54.21% to $2.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $2.0 million in Q3 2025, $3.5 million in Q2 2025, and $2.8 million in Q1 2025.